Krystal Biotech, Inc. is using gene therapy to develop effective and novel treatments for skin diseases.

Biotechnology

Krystal Biotech

Krish Krishnan is the current Chairman and CEO of [Krystal Biotech](/org/krystal-biotech). Krish has also served as the Chief Operating Officer of Intrexon Corporation from December 2011 to March 2016. Prior to that, they were the Chief Executive Officer of Pinnacle Pharmaceuticals from January 2009 to October 2011. Krishnan has also been a part of SKN, LLC. and Third Security LLC.

Krish Krishnan has a Master of Business Administration (MBA) from The Wharton School and a B.S. in Engineering from IIT/UPenn.

Kat Tuminello - Human Resources and Office Manager, Carrie Miller - Director, Quality Control, and Suma Krishnan - Founder and Chief Operations Officer report to Krish Krishnan.

Krish Krishnan

Cathy Trumpower is the Director of GMP Manufacturing at [Krystal Biotech](/org/krystal-biotech). Cathy has over 15 years of experience in the biotech industry, with a focus on manufacturing.

Cathy started their career at Stemnion, Inc. in August 2005 as a Manufacturing Manager. Cathy was with the company for over 10 years, until they left in January 2016 to join Noveome Biotherapeutics, Inc. as an Associate Director of Manufacturing. Cathy was with Noveome for two years before joining [Krystal Biotech](/org/krystal-biotech) in September 2018.

Cathy Trumpower has a BS in Biochemistry and Biophysics from the [University of Pittsburgh](/org/university-of-pittsburgh). Cathy is currently studying Biology/Biological Sciences, General at the university.

They work with Suma Krishnan - Founder and Chief Operations Officer, Jennifer Chien - Chief Commercial Officer, and Kat Tuminello - Human Resources and Office Manager. Cathy Trumpower reports to Krish Krishnan, Chairman & CEO, Chairman.

Cathy Trumpower

Josh Suskin has over 17 years of experience in Human Resources and Operations. Josh is currently the Director of Human Resources and Operations at [Krystal Biotech](/org/krystal-biotech). Previously, they were the Director of People and Manufacturing at Edward Marc Brands, where they were responsible for leading the Human Resource team and overseeing two manufacturing facilities. Josh has also worked as an executive recruiter and talent acquisition consultant for PrincetonOne, specializing in pharmaceuticals, biotech, and financial services. Throughout their career, Josh has been a recipient of the PrincetonOne President's Club Award multiple times.

Josh Suskin has a BS in Marketing and Economics from the [University of Pittsburgh](/org/university-of-pittsburgh). Josh is certified by the Management and Strategy Institute in Six Sigma Lean Black Belt Professional and by [SHRM](/org/shrm) in [SHRM](/org/shrm)-SCP.

They are on a team with Jennifer Chien - Chief Commercial Officer, Rekha Gyanchandani - Associate Director, Analytical Development, and J. Christopher Naftzger - Chief Legal Officer and Corporate Secretary. Their manager is Krish Krishnan, Chairman & CEO, Chairman.

Josh Suskin

Chris Naftzger joined [Krystal Biotech](/org/krystal-biotech) as its Chief Legal Officer and Corporate Secretary in February 2020.  Prior to joining Krystal, he was Vice President, Deputy General Counsel and Assistant Secretary of Nabriva Therapeutics plc (NASDAQ: NBRV), where he was part of the team that transformed Nabriva from a clinical-stage to commercial-stage pharmaceutical company, with the launch of its lead product, XENLETATM, the first new systemic class of antibiotic approved in the U.S. in nearly two decades.  He also served as Vice President, General Counsel, Chief Compliance Officer, and Secretary of Unilife Corporation (NASDAQ: [UNIS](/org/unis), ASX: UNS), a developer and manufacturer of innovative drug delivery systems, where he was the company’s first general counsel and established the corporate legal and compliance functions following Unilife’s listing on NASDAQ.  Previously, Chris held senior in-house counsel positions with Chesapeake Corporation (NYSE: CSK) and [Koch Industries](/org/koch-industries).  After law school, Chris worked as a corporate associate at Dyer Ellis & Joseph, P.C. in Washington, DC, where he became a partner upon the firm’s merger with Blank Rome LLP.  Chris obtained his undergraduate degree from [Hampden-Sydney College](/org/hampden-sydney-college) and his law degree from the Willamette University College of Law, where he served as managing editor of the Willamette Law Review.

J. Christopher Naftzger

Chris Mason

Dr. Sutherland was President of Translate Bio prior to its acquisition by Sanofi. Before joining Translate Bio, Dr. Sutherland spent seven years at Sanofi, most recently as Senior Vice President and Global Head of Medical Affairs for Sanofi Genzyme, and prior to that, Head of Rare Diseases Development. Dr. Sutherland's strategic le leadership in clinical development and medical affairs has been critical to the development and launch of medicines for lysosomal storage diseases, rare blood and other genetic diseases, and pulmonary and immunological diseases. Before joining the biopharmaceutical industry, Dr. Sutherland was Professor of Medicine at the University of Colorado and Chief of Pulmonary and Critical Care Medicine at National Jewish Health in Denver, where he cared for patients and led an NIH-funded clinical and translational research program focused on severe asthma and other complicated pulmonary diseases.

Rand Sutherland

Pooja Agarwal

Kirti Ganorkar

Dino A. Rossi

Dan Janney

Kat Tuminello

Doug Norby

Julian Gangolli

Suma Krishnan

Jennifer Chien has more than 20 years of commercial leadership experience in the biopharmaceutical industry.  Most recently, she was vice president, head of genetic diseases at Sanofi Genzyme where she was responsible for the U.S. commercial strategy and implementation for seven brands and preparation for upcoming launches within rare diseases. During her tenure at Sanofi Genzyme, she also held global leadership roles as VP, head of global nephrological diseases, senior director global marketing Fabry disease, senior director global market access and international marketing for the cardiovascular business, in addition to leading business development efforts within various therapeutic areas.  Jennifer holds a B.S. degree from Massachusetts Institute of Technology and a MPH degree from [Harvard University](/org/harvard).

Jennifer Chien

Rekha has over 10 years of experience in translational biomedical research. Prior to joining [Krystal Biotech](/org/krystal-biotech), Rekha was leading assay development for viral therapeutics at [Western Oncolytics](/org/western-oncolytics). Previously, as Research Instructor and Postdoctoral Associate at Magee-Womens Research Institute, her primary focus was breast cancer and key areas of research included drug resistance and biomarkers, liquid biopsy and mutation detection. She received her PhD in Molecular Pharmacology from the [University of Pittsburgh](/org/university-of-pittsburgh), where she studied resistance mechanisms to antiangiogenic therapies in head and neck cancer. In her spare time, Rekha enjoys social work volunteering, traveling, biking, and spending time with her family.

Rekha Gyanchandani

Carrie Miller has worked in the Pittsburgh Biopharmaceutical industry for 15+ years.  She has a strong background in multiple disciplines of drug development and manufacture including assay development, quality program management, cGMP manufacture, and facilities management.  She recently served as the Director of Analytics and Quality at [Western Oncolytics](/org/western-oncolytics). During her tenure at Western she built and managed the Quality Control Department, led tech transfer to CMO for virus and cell manufacture and oversaw the construction of the company’s new facility.  Carrie has two amazing sons, Jack (8) and Tucker (5), who keep her quite busy and exhausted.

Carrie Miller

Prior to her work with CNX, Romano was the corporate controller of Rice Energy from January 2013 until the energy company was acquired by EQT in November 2017, staying on through March 2018 to assist the company the company through the transition. She also held several accounting and auditing roles at Black Box Corp. and [Deloitte](/org/deloitte).

Krystal Biotech

Org chart

Teams

Leadership Team

Board of Directors

CEO and Executive Team

Founding Team

Discover similar companies